Moneycontrol PRO
Access insightful & curated financial content with Moneycontrol PRO at just Re. 1/- per day. Use code PRO365.
you are here: HomeNewsIndia

Coronavirus India | AIIMS Delhi treats dengue, COVID-19 coinfection case: Report

Doctors at the All India Institute of Medical Sciences have reported an increase in the number of both COVID-19 and dengue patients, and their major concern is the similarity in the initial symptoms of both.

September 15, 2020 / 06:35 PM IST
Representative Image

Representative Image

At a time when Delhi is grappling with a surge in COVID-19 cases, the national capital is also seeing a rise in dengue patients. Doctors at the All India Institute of Medical Sciences (AIIMS) have reported an increase in the number of both COVID-19 and dengue patients, and their major concern is the similarity in the initial symptoms of both.

More than 50 dengue patients have already been admitted to AIIMS this year, of which 42 cases came after the coronavirus pandemic outbreak in India. However, only one of these was a case of co-infection. Notably, a co-infection can be worrisome as both viruses cause cytokine storm, which can heighten the severity of the illness.

For live updates on coronavirus, click here

Doctors at AIIMS found themselves in a fix when a 30-year-old coronavirus patient tested positive for dengue also, reported the Indian Express. The woman had visited AIIMS on August 23 reporting symptoms such as fever, chills, body ache, and fatigue. Interestingly, she had not complained of any respiratory distress such as sore throat or cough. Later, doctors found out that her blood platelet count was low, which is common among dengue patients.

Dr Ashutosh Biswas, professor of Medicine, AIIMS, said: “We also suspected dengue as she had fever, muscle and joint pain, and low platelet count. She turned out to be positive for dengue NS1 antigen. Malaria test for PF and PV were negative.”


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

However, this woman kept testing positive for dengue till the tenth day of her illness, which is uncommon as most dengue patients test negative in a week. The doctors are yet to ascertain what might have led to this anomaly. Biswas added: “It is not clear why the infectivity period of dengue (NS1+ve) is increased in the presence of COVID-19 infection”. The woman was later cured and discharged from the hospital.

Follow our coverage of the coronavirus crisis here.
Moneycontrol News
first published: Sep 15, 2020 06:35 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark